A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers
Clinical trial NCT00863590 · COMPLETED
Trial details
- NCT number
- NCT00863590
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2005-02-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.